In a multicenter randomized phase 3 trial, stapokibart, a humanized monoclonal antibody that targets IL-4R alpha, significantly improved daily nasal and ocular symptom scores during the pollen ...

Inflammation is common, a natural way of the body to respond to infection. But it spells doom if it becomes consistent, paving way for many chronic illness. But fortunately this can be prevented ...

Inflammatory markers play a pivotal role in phenotyping asthma, assessing risks, and tailoring personalised therapeutic strategies, particularly in asthma associated with allergic sensitisation ...